BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22569408)

  • 41. GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas.
    Marcus C; Maragkos GA; Alterman RL; Uhlmann E; Pihan G; Varma H
    J Clin Neurosci; 2021 Jan; 83():49-55. PubMed ID: 33339691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intratumoral FOXP3+ Regulatory T Cells in Diffuse Large B-Cell Lymphoma.
    Serag El-Dien MM; Abdou AG; Asaad NY; Abd El-Wahed MM; Kora MAEM
    Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):534-542. PubMed ID: 26862953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
    Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
    Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinicopathologic features of breast lymphoma in core needle biopsy].
    Rao J; Ruan M; Yu BH; Li XQ; Yang WT; Shui RH
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):737-742. PubMed ID: 30317726
    [No Abstract]   [Full Text] [Related]  

  • 45. Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype.
    Sun J; Zhang J; Ling Q; Luo Y; Wu S; Liang Z; Zhong D; Zeng X
    Virchows Arch; 2015 Jan; 466(1):93-100. PubMed ID: 25403088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathologic analysis of localized nasal/paranasal diffuse large B-cell lymphoma.
    Toda H; Sato Y; Takata K; Orita Y; Asano N; Yoshino T
    PLoS One; 2013; 8(2):e57677. PubMed ID: 23469048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma.
    Hwang HS; Yoon DH; Suh C; Park CS; Huh J
    Blood Res; 2013 Dec; 48(4):266-73. PubMed ID: 24466551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas.
    Gaudio F; Tamma R; Ingravallo G; Perrone T; Laddaga FE; De Candia M; Maiorano E; Ribatti D; Specchia G
    Ann Hematol; 2018 Apr; 97(4):663-668. PubMed ID: 29362889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell Lymphoma.
    Xu Q; Tan C; Ni S; Wang Q; Wu F; Liu F; Ye X; Meng X; Sheng W; Du X
    Sci Rep; 2015 May; 5():10006. PubMed ID: 25940947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic Analysis Reveals Distinct Subtypes in Two Rare Cases of Primary Ovarian Lymphoma.
    Khattar P; Bedi P; Gonzalez M; Zhong M; Yin C; Huang W; Islam HK; Fallon JT
    Pathol Res Pract; 2018 Apr; 214(4):593-598. PubMed ID: 29519565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Advances in the Molecular Diagnosis and Therapy of Relapsed/Refractory Diffuse Large B-cell Lymphoma -Review].
    Wang Y; Xia B; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):603-608. PubMed ID: 29665940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the algorithms classifying the ABC and GCB subtypes in diffuse large B-cell lymphoma.
    Boltežar L; Prevodnik VK; Perme MP; Gašljević G; Novaković BJ
    Oncol Lett; 2018 May; 15(5):6903-6912. PubMed ID: 29731865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WHO reclassification of breast lymphomas.
    Loughrey MB; Windrum P; Catherwood MA; Alexander HD; Markey GM; McManus DT; Morris TC
    J Clin Pathol; 2004 Nov; 57(11):1213-4. PubMed ID: 15509687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinico-Pathologic Profile and Treatment Outcomes of Patients with Diffuse Large B Cell Lymphoma Based on Cell of Origin Classification.
    Mandloi SS; Thumaty DB; Nisha Y; Kayal S; Ganesan P; Jacob SE; Basu D; Dubashi B
    Indian J Hematol Blood Transfus; 2021 Apr; 37(2):226-231. PubMed ID: 33867728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary central nervous system lymphoma: prognostication as per international extranodal lymphoma study group score and reactive CD3 collar.
    Kumari N; Krishnani N; Rawat A; Agarwal V; Lal P
    J Postgrad Med; 2009; 55(4):247-51. PubMed ID: 20083869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Subtypes, Apoptosis and Proliferation Status in Indonesian Diffuse Large B-Cell Lymphoma Cases.
    Snak Y; Indrawati ; Widayati K; Arfian N; Anggorowati N
    Asian Pac J Cancer Prev; 2018 Jan; 19(1):185-191. PubMed ID: 29373912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.
    Leivonen SK; Taskinen M; Cervera A; Karjalainen-Lindsberg ML; Delabie J; Holte H; Lehtonen R; Hautaniemi S; Leppä S
    Blood Cancer J; 2017 Aug; 7(8):e596. PubMed ID: 28841210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffuse large B-cell lymphoma of the breast: a distinct entity?
    Bierman PJ; Villanueva ML; Armitage JO
    Ann Oncol; 2008 Feb; 19(2):201-2. PubMed ID: 18187483
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantitative image analysis in the assessment of diffuse large B-cell lymphoma.
    Chabot-Richards DS; Martin DR; Myers OB; Czuchlewski DR; Hunt KE
    Mod Pathol; 2011 Dec; 24(12):1598-605. PubMed ID: 21841768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synchronous diffuse large B cell lymphomas of the endometrium and breast: a staging dilemma.
    Gleeson JP; Woods GB; Watson GA; Ryan J; Doyle E; Quinn F; O'Keane JC; McCaffrey JA
    Ir J Med Sci; 2017 Nov; 186(4):867-873. PubMed ID: 28470353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.